Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Florida Herald.
Press releases published on June 26, 2025
Rising Demand for Drones for Commercial & Military Applications Becoming a Booming Revenue Opportunity
GlobeNewswire
·
June 26, 2025
PALM BEACH, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Unmanned Aerial Vehicle (UAV) imagery service providers have been offering innovative opportunities for businesses in the construction …
Alliance Entertainment Secures Exclusive North American Distribution for Master Replicas Collectibles
GlobeNewswire
·
June 26, 2025
PLANTATION, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- Alliance Entertainment Holding Corporation (Nasdaq: AENT) (“Alliance” or the “Company”), a premier global distributor and fulfillment partner of entertainment and pop culture collectibles, today announced …
Increasing Adoption of Drones in Commercial Sectors Leading to a Revolution in Big Data Cloud Services
GlobeNewswire
·
June 26, 2025
PALM BEACH, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The increasing adoption of drones in commercial sectors is leading to a revolution in big data cloud services. Launching a drone to capture images is the preliminary step …
Upexi Announces Intent to List SEC-Registered Shares On-Chain via Superstate’s Opening Bell
GlobeNewswire
·
June 26, 2025
TAMPA, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, …
HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements
GlobeNewswire
·
June 26, 2025
MIRAMAR, Fla., June 26, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by …
ZyVersa Therapeutics Announces First Clinical Site Activation, Initiating Patient Recruitment for Cholesterol Efflux Mediator™ VAR 200’s Phase 2a Clinical Trial in Patients with Diabetic Kidney Disease (DKD)
GlobeNewswire
·
June 26, 2025
Initiation of patient recruitment marks a key milestone in the development of VAR 200, a potential first-in-class treatment for kidney disease addressing renal lipotoxicity. There are no available drugs targeting renal lipotoxicity that damages the kidneys …